Drug Therapy, Combination
"Drug Therapy, Combination" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Therapy with two or more separate preparations given for a combined effect.
| Descriptor ID |
D004359
|
| MeSH Number(s) |
E02.319.310
|
| Concept/Terms |
Drug Therapy, Combination- Drug Therapy, Combination
- Combination Chemotherapy
- Drug Polytherapy
- Drug Polytherapies
- Polytherapies, Drug
- Polytherapy, Drug
- Therapy, Combination Drug
- Chemotherapy, Combination
- Chemotherapies, Combination
- Combination Chemotherapies
- Combination Drug Therapy
- Combination Drug Therapies
- Drug Therapies, Combination
- Therapies, Combination Drug
|
Below are MeSH descriptors whose meaning is more general than "Drug Therapy, Combination".
Below are MeSH descriptors whose meaning is more specific than "Drug Therapy, Combination".
This graph shows the total number of publications written about "Drug Therapy, Combination" by people in this website by year, and whether "Drug Therapy, Combination" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1991 | 3 | 125 | 128 |
| 1992 | 3 | 145 | 148 |
| 1993 | 15 | 163 | 178 |
| 1994 | 21 | 181 | 202 |
| 1995 | 25 | 206 | 231 |
| 1996 | 24 | 257 | 281 |
| 1997 | 24 | 255 | 279 |
| 1998 | 35 | 314 | 349 |
| 1999 | 24 | 378 | 402 |
| 2000 | 15 | 423 | 438 |
| 2001 | 32 | 398 | 430 |
| 2002 | 65 | 1436 | 1501 |
| 2003 | 93 | 1705 | 1798 |
| 2004 | 63 | 1845 | 1908 |
| 2005 | 53 | 2006 | 2059 |
| 2006 | 15 | 2112 | 2127 |
| 2007 | 9 | 2098 | 2107 |
| 2008 | 18 | 2359 | 2377 |
| 2009 | 22 | 2366 | 2388 |
| 2010 | 42 | 2500 | 2542 |
| 2011 | 52 | 2435 | 2487 |
| 2012 | 44 | 2443 | 2487 |
| 2013 | 36 | 2469 | 2505 |
| 2014 | 52 | 2476 | 2528 |
| 2015 | 53 | 2546 | 2599 |
| 2016 | 59 | 2560 | 2619 |
| 2017 | 91 | 2516 | 2607 |
| 2018 | 80 | 2136 | 2216 |
| 2019 | 21 | 805 | 826 |
| 2020 | 8 | 327 | 335 |
| 2021 | 2 | 42 | 44 |
To return to the timeline, click here.
Below are the most recent publications written about "Drug Therapy, Combination" by people in Profiles.
-
The preclinical inhibitor GS441524 in combination with GC376 efficaciously inhibited the proliferation of SARS-CoV-2 in the mouse respiratory tract. Emerg Microbes Infect. 2021 Dec; 10(1):481-492.
-
Effect of a genetically engineered interferon-alpha versus traditional interferon-alpha in the treatment of moderate-to-severe COVID-19: a randomised clinical trial. Ann Med. 2021 12; 53(1):391-401.
-
Beneficial effect of combinational methylprednisolone and remdesivir in hamster model of SARS-CoV-2 infection. Emerg Microbes Infect. 2021 Dec; 10(1):291-304.
-
Multicenter point prevalence evaluation of the utilization and safety of drug therapies for COVID-19 at the onset of the pandemic timeline in the United States. Am J Health Syst Pharm. 2021 03 18; 78(7):568-577.
-
Inhibition of Arenaviruses by Combinations of Orally Available Approved Drugs. Antimicrob Agents Chemother. 2021 03 18; 65(4).
-
COVID-19 Evidence Accelerator: A parallel analysis to describe the use of Hydroxychloroquine with or without Azithromycin among hospitalized COVID-19 patients. PLoS One. 2021; 16(3):e0248128.
-
Early antiviral treatment in outpatients with COVID-19 (FLARE): a structured summary of a study protocol for a randomised controlled trial. Trials. 2021 Mar 08; 22(1):193.
-
Success of prophylactic antiviral therapy for SARS-CoV-2: Predicted critical efficacies and impact of different drug-specific mechanisms of action. PLoS Comput Biol. 2021 03; 17(3):e1008752.
-
Effect of triple antimicrobial therapy on electrocardiography parameters in patients with mild-to-moderate coronavirus disease 2019. Anatol J Cardiol. 2021 03; 25(3):184-190.
-
Balanced evaluation of preliminary data on a candidate COVID-19 hydroxychloroquine treatment. Int J Antimicrob Agents. 2021 Mar; 57(3):106292.